Role of Immunotherapy Expanding in Head and Neck Cancer – OncLive
OncLiveRole of Immunotherapy Expanding in Head and Neck CancerOncLiveThe field already has 2 immunotherapy approvals with PD-1 agents. Pembrolizumab (Keytruda) was granted an accelerated approval by the FDA in August 2016 for the treatment of patients … Continue reading
